Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Alexander, Reichart"'
Autor:
Sonia Jaramillo, Lucian Le Cornet, Markus Kratzmann, Johannes Krisam, Martin Görner, Mathias Hänel, Christoph Röllig, Maxi Wass, Sebastian Scholl, Mark Ringhoffer, Alexander Reichart, Björn Steffen, Sabine Kayser, Jan-Henrik Mikesch, Kerstin Schaefer-Eckart, Jörg Schubert, Thomas Geer, Sonja Martin, Meinhard Kieser, Tim Sauer, Katharina Kriegsmann, Michael Hundemer, Hubert Serve, Martin Bornhäuser, Carsten Müller-Tidow, Richard F. Schlenk
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-15 (2023)
Abstract Background About 50% of older patients with acute myeloid leukemia (AML) fail to attain complete remission (CR) following cytarabine plus anthracycline-based induction therapy. Salvage chemotherapy regimens are based on high-dose cytarabine
Externí odkaz:
https://doaj.org/article/429cfaca4e8047249e5f275e8cfc363c
Autor:
Sonia Jaramillo, Lucian Le Cornet, Markus Kratzmann, Johannes Krisam, Martin Görner, Mathias Hänel, Christoph Röllig, Maxi Wass, Sebastian Scholl, Mark Ringhoffer, Alexander Reichart, Björn Steffen, Sabine Kayser, Jan-Henrik Mikesch, Kerstin Schaefer-Eckart, Jörg Schubert, Thomas Geer, Sonja Martin, Meinhard Kieser, Tim Sauer, Katharina Kriegsmann, Michael Hundemer, Hubert Serve, Martin Bornhäuser, Carsten Müller-Tidow, Richard F. Schlenk
Background: About 50% of older patients with acute myeloid leukemia (AML) fail to attain complete remission (CR) following cytarabine plus anthracycline-based induction therapy. Salvage chemotherapy regimens are based on high dose cytarabine (HiDAC),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e51c112431cc5fdbcd02ca3005cae904
https://doi.org/10.21203/rs.3.rs-1117424/v1
https://doi.org/10.21203/rs.3.rs-1117424/v1
Autor:
Jens Papke, Holger Schulz, Alexander Reichart, Jürgen Wehmeyer, Eike Gallmeier, Petra Büchner-Steudel, Martin Wolf, Lutz Jacobasch, Jan Wierecky, Klaus-Ulrich Däßler, Mark-Oliver Zahn, Salah-Eddin Al-Batran, Hans-Detlev Harich, Jörg Weniger, Lars Hahn, U. R. Peters, Dirk Behringer, Daniel Pink, Hans-Peter Feustel, Heinz-Gert Höffkes, Thomas Fietz, Marina Schaaf, Matthias Groschek, Claudia Pauligk, Arndt Vogel, Oliver Waidmann, Jens Uhlig, Steffen Dörfel, Ursula Vehling-Kaiser, G. Schuch, Wolfgang Blau, Helmut Forstbauer, Ludwig Fischer von Weikersthal, Martina Stauch, Arbeitsgemeinschaft Internistische Onkologie, Stephan Bildat, Jörg Schubert, Stefan Mahlmann, Michael Koenigsmann, Rudolf Schlag, Henning Eschenburg, Jörg Trojan, Albrecht Kretzschmar, Volker Kunzmann, Uwe Schwindel, Caroline Schönherr, Karin Waibel, Nils Homann, Ali Aldaoud, Thorsten Oliver Götze, Gerrit zur Hausen, Gabriele Margareta Siegler, Christoph Springfeld, Ralf-Dieter Hofheinz, Helmut Messmann, Marcus-A Wörns, Thomas J. Ettrich
Publikováno v:
International Journal of Cancer. 148:1478-1488
Few data exist on health-related quality of life (QoL) in patients with metastatic pancreatic cancer (mPC) receiving first-line chemotherapy (Awad L ZE, Mesbah M Boston, MA. Applying survival data methodology to analyze quality of life data, in Mesba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f49ed33d11961538a1152d28c1944a2
https://doi.org/10.1002/ijc.33336
https://doi.org/10.1002/ijc.33336
Autor:
Alexander Reichart, Nils Homann, Thomas J. Ettrich, Salah-Eddin Al-Batran, Volker Kunzmann, Gabriele Margareta Siegler, Jörg Trojan, Daniel Pink, Claudia Pauligk, Arndt Vogel, Rudolf Schlag, Wolfgang Blau, Marina Schaaf, Thorsten Oliver Goetze, Oliver Waidmann, Caroline Schoenherr, Heinz-Gert Hoeffkes, Gerrit zur Hausen, Helmut Messmann, Ralf Hofheinz
Publikováno v:
Web of Science
Publons
Publons
4625 Background: Gemcitabine and nab-paclitaxel (NPG) is standard first-line therapy for metastatic pancreatic cancer (mPC), but the pivotal study did not include quality of life (QoL) analyses. Methods: The QOLIXANE-PARAGON study started as a prospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4c1107bb17f26d7044164ac4bcaf1ca
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/89663
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/89663
Autor:
Matthias Egger, Stephan Probst, Jörg Trojan, Alexander Reichart, Dirk M Behringer, Salah-Eddin Al-Batran, Volker Rethwisch, Michael Pohl, Gerald Illerhaus, Jan Stoehlmacher, Jörg Weniger, Daniel Pink, Wael Hozaeel, Rolf Mahlberg, Georg Martin Haag, Severin Daum, Carmen Löhr, Wolff Schmiegel, Michael Heike, G. Schuch, Timo Gaiser, Flot Aio Investigators, Thorsten Oliver Goetze, Helga Bernhard, Sebastian Belle, Nils Homann, Johannes Meiler, Hans-Georg Kopp, Nicole Prasnikar, Christian Teschendorf, Andreas Block, Michael Schenk, Volker Heinemann, Markus Moehler, Stefan Kasper, Claudia Pauligk, Kim Barbara Luley, Ralf Hofheinz, Harald Schmalenberg, Michael Kneba, Frank Kullmann, Wolf O. Bechstein, Jörg T. Hartmann, Uwe M. Martens, Martin Schuler, U. Lindig, Fuat Oduncu, Peter C. Thuss-Patience, Thomas Kraus, Gunnar Folprecht, Frank Mayer, Michael Koenigsmann, Elke Jäger, Wolfgang Fischbach, Stefan Mönig, Ludwig Fischer von Weikersthal, Martina Güntner, Karsten Schulmann
Publikováno v:
The Lancet. 393:1948-1957
Background Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-oesophageal junction adenocarcinoma. This study reports on the safety and efficacy of the docetaxel-based triplet FLOT (fluorouracil plus leucovorin, oxaliplatin an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bb9328f246b91519e1997e982c1bc7c
https://doi.org/10.1016/s0140-6736(18)32557-1
https://doi.org/10.1016/s0140-6736(18)32557-1
Autor:
Salah-Eddin, Al-Batran, Ralf-Dieter, Hofheinz, Alexander, Reichart, Claudia, Pauligk, Caroline, Schönherr, Rudolf, Schlag, Gabriele, Siegler, Steffen, Dörfel, Michael, Koenigsmann, Mark-Oliver, Zahn, Jörg, Schubert, Ali, Aldaoud, Heinz-Gert, Höffkes, Holger, Schulz, Lars, Hahn, Jens, Uhlig, Wolfgang, Blau, Martina, Stauch, Jörg, Weniger, Martin, Wolf, Lutz, Jacobasch, Stephan, Bildat, Jürgen, Wehmeyer, Nils, Homann, Jörg, Trojan, Oliver, Waidmann, Thomas, Fietz, Hans-Peter, Feustel, Matthias, Groschek, Jan, Wierecky, Karin, Waibel, Stefan, Mahlmann, Uwe, Schwindel, Uwe, Peters, Gunter, Schuch, Daniel, Pink, Henning, Eschenburg, Marcus-A, Wörns, Hans-Detlev, Harich, Ludwig Fischer, von Weikersthal, Klaus-Ulrich, Däßler, Dirk M, Behringer, Helmut, Messmann, Albrecht, Kretzschmar, Eike, Gallmeier, Helmut, Forstbauer, Volker, Kunzmann, Jens, Papke, Petra, Büchner-Steudel, Ursula, Vehling-Kaiser, Christoph, Springfeld, Arndt, Vogel, Thomas J, Ettrich, Marina, Schaaf, Gerrit Zur, Hausen, Thorsten Oliver, Götze
Publikováno v:
International journal of cancerREFERENCES. 148(6)
Few data exist on health-related quality of life (QoL) in patients with metastatic pancreatic cancer (mPC) receiving first-line chemotherapy (Awad L ZE, Mesbah M Boston, MA. Applying survival data methodology to analyze quality of life data, in Mesba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5ba8201916c628cf641bb473a0c2c39
https://pubmed.ncbi.nlm.nih.gov/33038277
https://pubmed.ncbi.nlm.nih.gov/33038277
Autor:
Raphael Mwangi, Matthew J. Maurer, Colleen Ramsower, Timothy J. McDonnell, Andrew L. Feldman, Eva Giné, James R. Cook, Philipp W. Raess, Jonathon B. Cohen, Alexander Reichart, Brian T. Hill, German Ott, Lisa M. Rimsza, Diego Villa, Thomas M. Habermann, Ryan S. Robetorye, David W. Scott, Elias Campo, Allison C. Rosenthal
Publikováno v:
Blood. 138:3517-3517
BACKGROUND: Mantle cell lymphoma (MCL) is a B-cell non-Hodgkin lymphoma with variable clinical outcomes. Commonly used risk stratification tools (Ki67 IHC, MIPI) in newly diagnosed MCL are not frequently used when selecting therapy, resulting in trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2330a7c21540cd555908b1c6f53cc37b
https://doi.org/10.1182/blood-2021-151275
https://doi.org/10.1182/blood-2021-151275
Autor:
Jörg Trojan, Marino Venerito, Claus Bolling, Thorsten Oliver Goetze, Gabriele Margareta Siegler, Michael Varvenne, Nils Homann, Alexander Reichart, Wael Hozaeel, Karsten Kratz-Alber, Dirk Behringer, Claudia Pauligk, Ulli Simone Bankstahl, Wolf O. Bechstein, Jochem Potenberg, Matthias Behrend, Wolfram Bohle, Thomas Kraus, Salah-Eddin Al-Batran
Publikováno v:
Journal of Clinical Oncology. 39:406-406
406 Background: The outcome of pancreatic cancer remains poor. Few patients (pts) can be assigned to surgery and 80% of resected pts experience a relapse. Currently, adjuvant ctx is standard, but prognosis remains poor. FOLFIRINOX (FFX) is a SOC in m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf3ee4f1307c4e90d0a061171c172314
https://doi.org/10.1200/jco.2021.39.3_suppl.406
https://doi.org/10.1200/jco.2021.39.3_suppl.406
Autor:
B. Krammer-Steiner, D.W. Müller, C. Prause, N. Kosic, Michael Geißler, Gabriele Margareta Siegler, E de Toni, S-E. Al-Batran, Martin Walker, Tobias Müller, Frank Lammert, Alexander Reichart, Arndt Vogel, M. Schultheiss, U. Lindig, Jürgen Siebler
Publikováno v:
Annals of Oncology. 31:S691
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9027606ea42db2e2fb1d7c3697bbf8b6
https://doi.org/10.1016/j.annonc.2020.08.1104
https://doi.org/10.1016/j.annonc.2020.08.1104
Autor:
Daniel Pink, R.D. Hofheinz, Rudolf Schlag, C. Schönherr, Wolfgang Blau, T.O. Götze, Helmut Messmann, Oliver Waidmann, Volker Kunzmann, Gabriele Margareta Siegler, S-E. Al-Batran, G. zur Hausen, Alexander Reichart, Joerg Trojan, Nils Homann, Marina Schaaf, Claudia Pauligk, H-G. Hoeffkes, Arndt Vogel, Thomas J. Ettrich
Publikováno v:
Annals of Oncology. 31:S939
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d48237ec74f20c87663d4d4abfe77480
https://doi.org/10.1016/j.annonc.2020.08.2008
https://doi.org/10.1016/j.annonc.2020.08.2008